The metabolic implications of long term cannabis use in patients with psychosis

被引:4
|
作者
Mushtaq, Farrah [1 ]
Mondelli, Valeria [1 ]
Pariante, Carmine M. [1 ]
机构
[1] Kings Coll London, Inst Psychiat, James Black Ctr,Div Psychol Med, Ctr Cellular Basis Behav,SPI Lab, London SE5 9NU, England
基金
英国医学研究理事会;
关键词
cannabis; psychosis; weight; metabolic syndrome;
D O I
10.1017/S1121189X00001317
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Aims - The aim of this paper is to summarise the effects of cannabis use on appetite and energy balance, and to subsequently investigate the possible implications this may have in patients with psychosis, in whom a high prevalence of cannabis use has been reported. Methods - A narrative review based on the recent literature regarding cannabis use in the general population and patients with psychosis. Results - The short-term abilities of cannabis to increase appetite and body weight, through actions on the endogenous endocannabinoid system, have been well characterised throughout the literature. The long term effects of cannabis use are however unclear and only a minority of studies have been conducted in the genera. population with overall conflicting results. In terms of the effects of cannabis in patients with psychosis, there has only been one study to date that has investigated this and interestingly found cannabis use to be associated with increased body weight and blood glucose levels, thus providing evidence that cannabis use may be an important contributing factor to the reduced life expectancy, as is Currently observed in this vulnerable patient group. Conclusions - It is clear from the literature that patients with psychosis are at a high risk of metabolic and cardiovascular disease in comparison to the general population. However the contribution of cannabis use to this risk is as of yet undetermined and further long term studies are need to confirm Current findings and evaluate hypothesised mechanisms.
引用
收藏
页码:221 / 226
页数:6
相关论文
共 50 条
  • [1] Cannabis Use in Psychosis: the Effects On Metabolic Health
    Bruins, J.
    Bruggeman, R.
    Visser, E.
    Bartels, A.
    Van den Heuvel, E.
    Pijnenborg, M.
    Jorg, F.
    EUROPEAN PSYCHIATRY, 2015, 30
  • [2] CANNABIS USE IN PSYCHOSIS: THE EFFECTS ON METABOLIC HEALTH
    Bruggeman, Richard
    Van Beveren, Nico J. M.
    Liemburg, Edith
    Bruins, Jojanneke
    SCHIZOPHRENIA BULLETIN, 2015, 41 : S134 - S134
  • [3] Long-term heavy cannabis use: Implications for health education
    Coggans, N
    Dalgarno, P
    Johnson, L
    Shewan, D
    DRUGS-EDUCATION PREVENTION AND POLICY, 2004, 11 (04) : 299 - 313
  • [4] WHAT ARE THE POLICY IMPLICATIONS OF THE EVIDENCE ON CANNABIS USE AND PSYCHOSIS?
    Hall, Wayne
    Degenhardt, Louisa
    ADDICTION, 2010, 105 (08) : 1332 - 1333
  • [5] Impact of cannabis use and cannabis cessation on inflammation in patients with psychosis
    Romeo, B.
    Lestra, V.
    Martelli, C.
    Amirouche, A.
    Benyamina, A.
    Hamdani, N.
    EUROPEAN PSYCHIATRY, 2023, 66 : S254 - S255
  • [6] The Role of Cannabis Use on Cognition and Metabolic Factors in Individuals With Psychosis
    Rhilinger, Joshua
    Gugava, Lia
    Tevelev, Stacey
    Carter, Cameron
    Lesh, Tyler
    BIOLOGICAL PSYCHIATRY, 2023, 93 (09) : S282 - S283
  • [7] Treating cannabis use disorders in patients with psychosis
    Hjorthoj, Carsten R.
    Fohlmann, Allan
    Larsen, Anne-Mette
    Gluud, Christian
    Arendt, Mikkel
    Nordentoft, Merete
    EARLY INTERVENTION IN PSYCHIATRY, 2012, 6 : 6 - 6
  • [8] The antipsychotic potential of cannabidiol: clinical implications for patients with psychosis and comorbid cannabis use disorder
    Garel, Nicolas
    Greenway, Kyle T.
    Joober, Ridha
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2021, 46 (01): : E164 - E165
  • [9] CANNABIS USE AND PSYCHOSIS
    Morrison, P.
    Murray, R.
    Di Forti, M.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2012, 36 : 14A - 14A
  • [10] Cannabis use and psychosis
    Hall, W
    DRUG AND ALCOHOL REVIEW, 1998, 17 (04) : 433 - 444